TITLE

Second-Generation Antiepileptic Drugs' Impact on Balance: A Meta-analysis

AUTHOR(S)
Sirven, Joseph I.; Terry D. Fwe; Wingerchuk, Dean M.; Drazkowski, Joseph F.
PUB. DATE
January 2007
SOURCE
Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To systematically review available evidence regarding whether second-generation antiepileptic drugs (AED5) contribute to the risk of balance disorders. METHODS: We systematically evaluated data from randomized controlled trials that compared adjunctive therapy with a second-generation AED (gabapentin, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, tiagabine, topiramate, or zonisamide) vs placebo for partial epilepsy and that reported dose-specific rates of ataxia or imbalance for each group. Random-effects meta-analysis was used to pool ratios (risk ratio [RR]) and associated 95% confidence intervals to determine whether there was evidence of an overall AED class effect or a dose-response effect and whether there were differences between individual AEDs. RESULTS: Sixteen studies met inclusion criteria, representing 4279 individuals randomized to a second-generation AED and 1830 patients to placebo. Pooled analyses of all AEDs demonstrated that they increase imbalance risk at any dose (RR, 2.73; 95% confidence Interval, 2.07-3.61) and at lowest dose (RR, 1.76; 95% confidence Interval, 1.26-2.46). The highest dose analysis showed heterogeneity; evaluation of individual AEDs revealed that oxcarbamazepine and topiramate increased imbalance risk at all doses, whereas gabapentin and levetiracetam did not increase imbalance risk at any dose. A dose-response effect was observed for most AEDs. CONCLUSION: Second-generation AEDs at standard dosages, except for gabapentin and levetiracetam, increase the imbalance risk, and evidence exists for a dose-response effect. The mechanisms, risk factors, and consequences of this risk for individual AEDs warrant further study.
ACCESSION #
23737583

 

Related Articles

  • Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. DeGiorgio, Christopher M.; Miller, Patrick R.; Harper, Ronald; Gornbein, Jeffrey; Schrader, Lara; Soss, Jason; Meymandi, Sheba // Journal of Neurology, Neurosurgery & Psychiatry;Jan2015, Vol. 86 Issue 1, p65 

    Background n-3 fatty acids inhibit neuronal excitability and reduce seizures in animal models. High-dose fish oil has been explored in two randomised trials in drug resistant epilepsy with negative results. We performed a phase II randomised controlled crossover trial of lowdose and high-dose...

  • Greater Response to Placebo in Children Than in Adults: A Systematic Review and Meta-Analysis in Drug-Resistant Partial Epilepsy. Rheims, Sylvain; Cucherat, Michel; Arzimanoglou, Alexis; Ryvlin, Philippe // PLoS Medicine;Aug2008, Vol. 5 Issue 8, pe166 

    In a systematic review of antiepileptic drugs, Philippe Ryvlin and colleagues find that children with drug-resistant partial epilepsy enrolled in trials seem to have a greater response to placebo than adults enrolled in such trials.

  • Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Haddad, Rudy M.; Kennedy, Cassie C.; Caples, Sean M.; Tracz, Michal J.; Boloña, Enrique R.; Sideras, Kostandinos; Uraga, Maria V.; Erwin, Patricia J.; Montori, Victor M. // Mayo Clinic Proceedings;Jan2007, Vol. 82 Issue 1, p29 

    OBJECTIVE: To conduct a systematic review and meta-analysis of randomized trials that assessed the effect of testosterone use on cardiovascular events and risk factors in men with different degrees of androgen deficiency. METHODS: Librarian-designed search strategies were used to search the...

  • Greater Response to Placebo in Children Than in Adults: A Systematic Review and Meta-Analysis in Drug-Resistant Partial Epilepsy. Rheims, Sylvain; Cucherat, Michel; Arzimanoglou, Alexis; Ryvlin, Philippe // PLoS Clinical Trials;Aug2008, Vol. 5 Issue 8, p1223 

    Background Despite guidelines establishing the need to perform comprehensive paediatric drug development programs, pivotal trials in children with epilepsy have been completed mostly in Phase IV as a postapproval replication of adult data. However, it has been shown that the treatment response...

  • Epilepsy Drug Linked to Heart Attack Risk. Gerson, Charlotte // Gerson Healing Newsletter;Jul/Aug2007, Vol. 22 Issue 4, p6 

    The article focuses on the probable association of heart attack risks and antiepileptic drugs. According to the author, a doctor from Vicenza, Italy has been researching one aspect of drug therapy for epilepsy and has made the discovery that drugs like Phenobarbital appear to raise the...

  • Treatment options for poststroke seizures extrapolated from those for epilepsy. Adis International Limited // Drugs & Therapy Perspectives;Jul2005, Vol. 21 Issue 7, p7 

    Looks at some treatment options for poststroke seizures. Cumulative probabilities of developing seizures by 5 years after stroke, according to community-based, prospective cohort studies; Risk factors for recurrent seizures; Variety of antiepileptic drugs.

  • Lamotrigine as an Effective Treatment for Behavioral Disorders. Rita Moretti; Paola Torre; Cristina Vilotti; Rodolfo M. Antonello // Letters in Drug Design & Discovery;Aug2007, Vol. 4 Issue 6, p446 

    Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In...

  • Eslicarbazepine Acetate: A Review of Its Use as Adjunctive Therapy in Refractory Partial-Onset Seizures. Keating, Gillian // CNS Drugs;Jul2014, Vol. 28 Issue 7, p583 

    Eslicarbazepine acetate (Aptiom, Zebinix) is approved for the adjunctive treatment of partial-onset seizures in adults aged ≥18 years. Adjunctive therapy with oral eslicarbazepine acetate 800 or 1,200 mg once daily was associated with a significantly lower standardized seizure frequency...

  • Effect of Melatonin on Seizure Frequency in Intractable Epilepsy: A Pilot Study. Goldberg-Stern, Hadassa; Oren, Heftsiba; Peled, Nir; Garty, Ben-Zion // Journal of Child Neurology;Dec2012, Vol. 27 Issue 12, p1524 

    Melatonin is effective for treating sleep–wake cycle disturbances and has been reported occasionally to decrease epileptic seizure frequency, with no long-term side effects. In this pilot study, the investigators examined the effect of melatonin on seizures, sleep quality, and behavior in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics